Bluejay Diagnostics Files Definitive Proxy Statement

TL;DR

Bluejay Diagnostics DEF 14A filed. Vote on directors & auditors Aug 21.

AI Summary

Bluejay Diagnostics, Inc. filed a definitive proxy statement (DEF 14A) on July 16, 2024, for its annual meeting of stockholders scheduled for August 21, 2024. The filing outlines the company's governance and proposals to be voted on by shareholders, including the election of directors and ratification of its independent registered public accounting firm. The company is based in Acton, MA, and operates in the surgical and medical instruments sector.

Why It Matters

This filing provides shareholders with crucial information to make informed voting decisions on company leadership and important corporate matters at the upcoming annual meeting.

Risk Assessment

Risk Level: low — This is a routine proxy filing detailing upcoming shareholder votes and company governance, not indicating new financial risks.

Key Numbers

• DEF 14A — Filing Type (Definitive Proxy Statement)

Key Players & Entities

• Bluejay Diagnostics, Inc. (company) — Registrant
• 0001213900-24-061784 (filing_id) — Accession Number
• 20240716 (date) — Filing Date
• 20240821 (date) — Meeting Date
• Acton, MA (location) — Company Address

FAQ

Key Financial Figures

• $25,000 — e expect to pay Saratoga Proxy a fee of $25,000, plus reimbursement of reasonable and c
• $0.0001 — capital stock, each with a par value of $0.0001 per share, which the Corporation is aut

Filing Documents

• ea0208857-02.htm (DEF 14A) — 334KB
• tproxy_001.jpg (GRAPHIC) — 1430KB
• tproxy_002.jpg (GRAPHIC) — 1148KB
• 0001213900-24-061784.txt ( ) — 3886KB

From the Filing

DEF 14A 1 ea0208857-02.htm PROXY STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________________ SCHEDULE 14A _________________________________ Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant   Filed by a Party other than the Registrant   Check the appropriate box:   Preliminary Proxy Statement   Confidential, for Use of the Commission Only (as permitted by Rule 14a -6 (e)(2))   Definitive Proxy Statement   Definitive Additional Materials   Soliciting Material under §240.14a -12 Bluejay Diagnostics, Inc. (Name of Registrant as Specified In Its Charter) ______________________________________________________________ (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check all boxes that apply):   No fee required.   Fee paid previously with preliminary materials.   Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a -6 (i)(1) and 0 -11 .   Table of Contents July 16, 2024 Dear Fellow Bluejay Diagnostics, Inc. Stockholders: We invite you to attend a Special Meeting of Stockholders of Bluejay Diagnostics, Inc. on August 21, 2024 (the “Special Meeting”). The Special Meeting will begin at 1:00 p.m. local time at the corporate offices of Bluejay Diagnostics, Inc., 360 Massachusetts Avenue, Suite 203, Acton, MA 01720. Information regarding each of the matters to be voted on at the Special Meeting is contained in the attached Proxy Statement and Notice of Special Meeting of Stockholders. The Notice of Special Meeting of Stockholders sets forth the proposals that will be presented at the Special Meeting, which are described in more detail in the Proxy Statement. Your vote is very important to us. Even if you plan to attend the Special Meeting, we encourage all of our stockholders to review these proxy materials and vote your shares prior to the Special Meeting. On behalf of the Board of Directors, thank you for your continued confidence and investment in Bluejay Diagnostics, Inc.   Very truly yours,     BLUEJAY DIAGNOSTICS, INC.     /s/ Neil Dey     Neil Dey     President and Chief Executive Officer Important Notice Regarding the Availability of Proxy Materials for the Special Meeting of Shareholders to be Held on August 21 , 2024: An Electronic Copy of the Proxy Statement is available at https: // www.cstproxy.com / bluejaydx / sm2024   Table of Contents Bluejay Diagnostics, Inc. 360 Massachusetts Avenue, Suite 203 Acton, MA 01720 (844) 327-7078 NOTICE OF SPECIAL MEETING OF STOCKHOLDERS TO BE HELD ON AUGUST 21 , 2024 TO THE STOCKHOLDERS OF BLUEJAY DIAGNOSTICS, INC.: NOTICE IS HEREBY GIVEN that a Special Meeting of Stockholders of Bluejay Diagnostics, Inc. (the “Company”) will be held at the corporate offices at 360 Massachusetts Avenue, Suite 203, Acton, MA 01720, on August 21, 2024 at 1:00 p.m., local time (the “Special Meeting”), for the following purposes, as described in the accompanying Proxy Statement:   Proposal 1.   To approve and adopt an amendment to the Company’s amended and restated certificate of incorporation, as amended, to increase the number of authorized shares of the Company’s common stock (the “Authorized Share Increase Proposal”);     Proposal 2.   To approve, in accordance with Nasdaq Listing Rule 5635(d), the issuance of the Class C warrants to purchase common stock in connection with an offering and sale of securities of the Company that was consummated on June 28, 2024 (the “Class C Warrant Proposal”);     Proposal 3.   To approve, in accordance with Nasdaq Listing Rule 5635(d), the issuance of the Class D warrants to purchase common stock in connection with an offering and sale of securities of the Company that was consummated on June 28, 2024 (the “Class D Warrant Proposal”); and     Proposal 4   To approve one or more adjournments of the Special Meeting, if necessary or appropriate, to solicit additional proxies in favor of any or all of the Authorized Share Increase Proposal, the Class C Warrant Proposal or the Class D Warrant Proposal, if there are not sufficient votes at the Special Meeting to approve and adopt any or all of the Authorized Share Increase Proposal, the Class C Warrant Proposal or the Class D Warrant Proposal (